Popular Articles

Aug 24, 2018
Pharmaceutical Executive
Lisa Henderson examines the rise and reach of biopharma in the key Northeast Corridor clusters of Boston, Philadelphia, and New Jersey.
Aug 10, 2018
Pharmaceutical Executive
Most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth.
Aug 07, 2018
Pharmaceutical Executive
New York City is emerging as a hotspot for biotech incubators, including one startup whose CEO made the leap from big pharma to forging new discoveries in medical science. Michelle Maskaly reports.
Aug 06, 2018
Pharmaceutical Executive
Over the last decade, Spain has seen a significant growth in venture-capital investment in the life sciences. We explore the driving forces.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
Jun 10, 2018
Pharmaceutical Executive
There is no magic bullet that will dramatically impact drug pricing to everybody’s liking. But a stepwise approach involving a series of reforms, including taking advantage of the next midterm elections, could point the path toward a solution.
Mar 16, 2018
James Burt, Accord Healthcare’s EVP, Europe and MENA, outlines his optimistic vision for the UK and Europe post-Brexit and the challenges of retaining a company culture amid major growth.
Feb 12, 2018
Pharmaceutical Executive
The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.
Feb 12, 2018
Pharmaceutical Executive
Lieutenant General (Ret) Rick Lynch, US Army, and Bob Jansen, CEO of Zensights, discuss the military-industry effort to instill the principles of adaptive leadership into today’s pharma leader.
Feb 12, 2018
Pharmaceutical Executive
Whether the pharma industry is navigating calm or choppy waters, it should be smarter and more assertive in telling its story to its stakeholders—most importantly, patients and the wider public.
native1_300x100
lorem ipsum